Bacteriological and clinical evaluation of cefotetan in the treatment of severe infections in hospitalized patients.

Abstract

The authors studied 302 hospitalized patients, 164 males and 138 females aged 15-88 years (average 66 years), with severe infections. Cefotetan was administered to 278 of them at the dose of 1 or 2 g, b.i.d. or a single daily dose i.m. Other patients [24] were treated with a continuous intravenous infusion of cefotetan (3 g daily in 5% dextrose). Of these… (More)

Topics

  • Presentations referencing similar topics